The European Brain Council has been involved in many projects ever since its creation. Its membership results from concerted discussions with its members organisations. In addition, members of project groups are appointed by the EBC leadership in order to find the best-suited experts throughout Europe be they doctors, basic scientists or expert patients.


Move for Your Brain

The European Brain Foundation and the European Brain Council have decided to shine a light on the benefits of physical exercise on the brain by reactivating its #Move4YrBrain campaign. Physical activity and healthy lifestyles have a clear and demonstrated impact on brain health. Whether you’re running, walking, or jogging, let’s lace up our shoes, hit the pavement, and boost our brain health together!


No Health Without Brain Health

The campaign, which will run until the formation of a new Parliament and Commission in the autumn, aims to increase attention for brain health, not only from within the wider brain community but also from EU policymakers and the public, to place the brain higher on health and research policy agendas to ensure that more resources are channelled towards prevention awareness, research on the brain and for the 179 million Europeans currently living with some form of brain condition. 


The Value of Treatment

Identify treatment gaps (or barriers to care) and causing factors along the care pathway and propose solutions to address them. Assess health gains and socio-economic impacts resulting from best practice healthcare interventions, in comparison with current care or no treatment. Converge evidence to policy.



EBC has created the #ILoveMyBrain logo as a communication tool for promoting and connecting all the work being done to promote brain health and prevent and treat brain disorders in Europe.


Good Off-Label Use Practice

The EBC actively supports the adoption of EU guidelines on off-label use of medicines, a policy option presented in the European Commission`s Study on off-label use of medicinal products in the European Union published in February 2017. Off-label use is the practice of using a medicine outside its authorised indication.

Interested in working with EBC in a collaborative project?
Learn more: